altimmune glp-1 stock sinks on mixed phase 2 MASH results for drug Altimmune Nosedives on Mixed Mid-Stage

Limitations and perspectives Therapeutic approaches targeting cardiac remodeling reversal, including monoclonal antibodies, peptide-based therapies, and AAV vectors, share similar translational challenges with cardiac regeneration strategies, particularly with respect to delivery efficiency and potential off-target effects

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an n-terminally truncated peptide that is a major endogenous metabolite in vivo

In fact, it seems to speed it up, causing malabsorption of carbs, and may make diarrhea worse in some cases

We are here to help you build a routine you can trust, rooted in bioavailability and transparency

First-time prescribing of ADMs decreased in September 2025, relative to June 2025 (-16.8%)

Central nervous system agents in the treatment of erectile dysfunction: how do they work